Our Valuable Clinical Insights & Research Papers
Evidence-based prescribing decisions call for access to real clinical data, not just marketing claims. The MEFTAL-SPAS® Medical Tips / Clinical Insights section brings together downloadable research papers, published studies, and clinical trial findings on the role of mefenamic acid and dicyclomine in managing dysmenorrhea and related spasmodic pain.
Clinical Evidence on Mefenamic Acid
This section includes peer-reviewed material such as an open clinical trial of mefenamic acid in primary dysmenorrhoea, a consensus study on mefenamic acid and dicyclomine in dysmenorrhea, and a review of treatment approaches for dysmenorrhea. Most of them have been published in the Indian Journal of Clinical Practice. Together, they offer a practical view of how this combination performs in real clinical settings.
PMS and Emerging Research
Beyond dysmenorrhea, you’ll find data on the effect of mefenamic acid on premenstrual syndrome (PMS) in women of reproductive age, along with newer research examining mefenamic acid as an NLRP3 inflammasome inhibitor, offering insight into its mechanism of action at a molecular level.
Why These Insights Matter
For gynaecologists, general practitioners, and other healthcare professionals, having quick access to clinical research on dysmenorrhea treatment supports more confident conversations with patients and helps validate prescribing choices with published evidence rather than anecdote alone.
Explore the Full Library
Each paper listed is available as a downloadable PDF for your reference or to share with colleagues. New additions are marked clearly, so you can stay current with the latest clinical insights on menstrual pain management. Pair these papers with our posters and pamphlets and expert videos to support both your clinical decisions and patient counselling.
Disclaimer: This section is intended for medical and healthcare practitioners for general education and information purposes only.
